SE7805590L - Forfarande for framstellning av aminoalkylderivat med farmaceutisk verkan - Google Patents

Forfarande for framstellning av aminoalkylderivat med farmaceutisk verkan

Info

Publication number
SE7805590L
SE7805590L SE7805590A SE7805590A SE7805590L SE 7805590 L SE7805590 L SE 7805590L SE 7805590 A SE7805590 A SE 7805590A SE 7805590 A SE7805590 A SE 7805590A SE 7805590 L SE7805590 L SE 7805590L
Authority
SE
Sweden
Prior art keywords
aminoal
procedure
preparation
pharmaceutical effect
derivatives
Prior art date
Application number
SE7805590A
Other languages
English (en)
Swedish (sv)
Inventor
B J Price
J W Clitherow
M D Dowle
R Hayes
J Bradshaw
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of SE7805590L publication Critical patent/SE7805590L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
SE7805590A 1977-05-17 1978-05-16 Forfarande for framstellning av aminoalkylderivat med farmaceutisk verkan SE7805590L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB20659/77A GB1601459A (en) 1977-05-17 1977-05-17 Aminoalkyl thiophene derivatives

Publications (1)

Publication Number Publication Date
SE7805590L true SE7805590L (sv) 1978-11-18

Family

ID=10149541

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7805590A SE7805590L (sv) 1977-05-17 1978-05-16 Forfarande for framstellning av aminoalkylderivat med farmaceutisk verkan

Country Status (15)

Country Link
US (1) US4239769A (no)
JP (2) JPS53144568A (no)
AU (1) AU519277B2 (no)
BE (1) BE867105A (no)
DE (1) DE2821409A1 (no)
DK (1) DK214778A (no)
ES (1) ES469952A1 (no)
FI (1) FI781386A (no)
FR (1) FR2391209A1 (no)
GB (1) GB1601459A (no)
IE (1) IE46811B1 (no)
NL (1) NL7805278A (no)
NZ (1) NZ187145A (no)
SE (1) SE7805590L (no)
ZA (1) ZA782478B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4539207A (en) * 1978-02-13 1985-09-03 Smith Kline & French Laboratories Limited Pyrimidine compounds
IN151188B (no) * 1978-02-13 1983-03-05 Smith Kline French Lab
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
JPS55120571A (en) * 1979-03-02 1980-09-17 Glaxo Group Ltd Heterocyclic derivative
PH18379A (en) * 1979-03-02 1985-06-19 Glaxo Group Ltd Triazole acylamines and pharmaceutical compositions thereof
NZ193009A (en) * 1979-03-02 1983-07-15 Glaxo Group Ltd 3-n-(( -aminoalkyl)(furyl thiophenyl or phenyl)(alkyl))-amino-1h-1,2,4-triazoles
JPS568352A (en) * 1979-07-03 1981-01-28 Shionogi & Co Ltd Aminoalkylvenzene derivative
EP0029303B1 (en) * 1979-10-22 1985-01-30 Glaxo Group Limited 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
EP0027744B1 (en) * 1979-10-23 1984-03-14 Glaxo Group Limited Thiophene derivatives, processes for the production thereof and pharmaceutical compositions containing them
US4382929A (en) * 1979-10-23 1983-05-10 Glaxo Group Limited Thiophene derivatives and their pharmaceutical compositions and method of use
JPS5681578A (en) * 1979-12-07 1981-07-03 Shionogi & Co Ltd Novel thioalkyl amide derivative
US4431802A (en) * 1979-12-10 1984-02-14 G. D. Searle & Co. N-Heterocyclyl-N-cyano-N-(heterocyclythioalkyl)-guanidines
US4491586A (en) * 1980-06-05 1985-01-01 Glaxo Group Limited Amine derivatives
EP0057981A3 (en) * 1981-02-09 1982-08-25 Beecham Group Plc Aromatic compounds, processes for their preparation and their use
DE3108753A1 (de) * 1981-03-07 1982-09-16 Degussa Ag, 6000 Frankfurt Neue substituierte alkyl-phenylsulfonylguanidine miteinem heterocyclischen rest
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
US4788184A (en) * 1981-05-18 1988-11-29 Bristol-Myers Company Substituted 3-cyclobutene-1,2-diones as anti-ulcer agents
WO1983002113A1 (en) * 1981-12-17 1983-06-23 Yuki, Hiroshi Propenylamine derivatives and drug containing same
DE3238867A1 (de) * 1982-10-20 1984-04-26 Ludwig Heumann & Co GmbH, 8500 Nürnberg Heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS5988458A (ja) * 1982-11-12 1984-05-22 Toyama Chem Co Ltd アミン誘導体およびその塩
DE3343884A1 (de) * 1982-12-08 1984-06-14 Degussa Ag, 6000 Frankfurt Neue ethendiamin- und guanidin-derivate
NL8303965A (nl) * 1982-12-08 1984-07-02 Degussa Nieuwe etheendiamine- en guanidine-derivaten; werkwijze voor het bereiden daarvan; geneesmiddelen die ze bevatten; werkwijze voor het bereiden van dergelijke geneesmiddelen; toepassing van de verbindingen voor het bereiden van geneesmiddelen en in de geneeskunde.
DE3404786A1 (de) * 1984-02-10 1985-08-14 Ludwig Heumann & Co GmbH, 8500 Nürnberg Neue alkanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
FR2571723B1 (fr) * 1984-10-12 1988-08-26 Lipha Derives de thieno et furo-(2,3-c) pyrroles, procedes de preparation et medicaments les contenant
EP0226653B1 (de) * 1985-12-20 1989-02-22 LITEF GmbH Verfahren zur Kurswinkelbestimmung mittels und zur automatischen Kalibration eines in einem Luftfahrzeug fest montierten Dreiachsen-Magnetometers
JPS6370615U (no) * 1986-10-28 1988-05-12
JPH05236847A (ja) * 1992-02-28 1993-09-17 Reishii:Kk 熱交換装置
US6291514B1 (en) 1998-02-09 2001-09-18 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2519325A (en) * 1947-01-04 1950-08-15 White Lab Inc Antihistamine compounds
US2556636A (en) * 1948-06-23 1951-06-12 Schering Corp gamma-substituted propylamine type antihistamines
US2604473A (en) * 1950-07-17 1952-07-22 Schering Corp Propylamine type antihistamines
GB1307539A (en) 1970-06-25 1973-02-21 Smith Kline French Lab Thiourea derivatives
GB1338169A (en) 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1397436A (en) 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives

Also Published As

Publication number Publication date
JPS6312069B2 (no) 1988-03-17
ZA782478B (en) 1979-04-25
NL7805278A (nl) 1978-11-21
US4239769A (en) 1980-12-16
JPS53144568A (en) 1978-12-15
IE780853L (en) 1978-11-17
ES469952A1 (es) 1979-09-16
JPS5510591B2 (no) 1980-03-17
FI781386A (fi) 1978-11-18
BE867105A (fr) 1978-11-16
NZ187145A (en) 1980-10-24
JPS55113776A (en) 1980-09-02
IE46811B1 (en) 1983-10-05
AU3567378A (en) 1979-11-08
DE2821409A1 (de) 1978-11-30
AU519277B2 (en) 1981-11-19
FR2391209A1 (fr) 1978-12-15
GB1601459A (en) 1981-10-28
FR2391209B1 (no) 1982-05-14
DK214778A (da) 1978-11-18

Similar Documents

Publication Publication Date Title
SE7805590L (sv) Forfarande for framstellning av aminoalkylderivat med farmaceutisk verkan
SE7805591L (sv) Forfarande for framstellning av aminoalkylbensen-derivat med farmaceutisk verkan
NO782791L (no) Fremgangsmaate for fremstilling av antivirale amin- og amidin-derivater
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
SE429338B (sv) Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan
FI772319A (fi) Anordning foer orientering av med bindemedel foersedda lignocellulosahaltiga delar
SE7701379L (sv) Forfarande for framstellning av bensendimetanolderivat med farmakologisk verkan
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE7804736L (sv) Forfarande for framstellning av isoindolinderivat med terapeutisk verkan
SE411671B (sv) Forfarande for framstellning av tripeptidderivat med terapeutisk verkan
SE440907B (sv) Forfarande for framstellning av imidazolderivat med farmaceutisk verkan
SE7800930L (sv) Forfarande for framstellning av bensensulfonamid- och bensenkarboxamidderivat med terapeutisk verkan
SE7703721L (sv) Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan
NO780390L (no) Fremgangsmaate for fremstilling av oleandomycin-derivater
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
SE7608538L (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
SE7805105L (sv) Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan
SE7608115L (sv) Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan
SE7708521L (sv) Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
SE7712219L (sv) Forfarande for framstellning av trans-5a-aryl-dekahydrobenzazpiner med terapeutisk verkan
SE7805324L (sv) Forfarande for framstellning av 3-bromftalid
NO771576L (no) Fremgangsmaate for fremstilling av di-n-propylacetonitril
NO780834L (no) Fremgangsmaate for fremstilling av isobutyramid-derivater
NO771577L (no) Fremgangsmaate for fremstilling av di-n-propylacetamid